title: Diagnosis and treatment of late-onset portal vein stenosis after pediatric living-donor liver transplantation.
abstract: OBJECTIVE
  Portal vein stenosis is a relatively rare complication after living-donor liver transplantation, which sometimes leads to a life-threatening event owing to gastrointestinal bleeding or graft failure. This study sought to evaluate the diagnoses and management of late-onset portal vein stenosis in pediatric living-donor liver transplants.
  
  
  METHODS
  Since September 2001, we performed 123 living-donor liver transplant procedures in 120 children, among which 109 children with a functioning graft at 6 months after living-donor liver transplant are included in this analysis. Seven instances of portal vein stenosis were diagnosed and were analyzed retrospectively.
  
  
  RESULTS
  The median age of the children was 5.3 years, and the median body weight was 19.2 kg. Portal vein stenosis was diagnosed at 11.2±3.1 months after living-donor liver transplantation. Whereas 3 children were asymptomatic, splenomegaly and/or massive ascites were observed in the remaining 4. Additionally, platelet counts were below the normal limit in 4 children. All children were treated with transhepatic balloon dilatation except 1. Intraluminal stent placement was needed in 1 child owing to resistance of balloon dilatation. The mean pressure gradient decreased from 12.4 to 3.2 mmHg after successful treatment. We did not observe any treatment-related complications. Portal venous patency was maintained in all children during posttreatment follow-up of 43.2±20.4 months. There were no recurrences of portal vein stenosis. One child died; the remaining 6 children are alive with good graft function at 49.8±23.9 months of follow-up.
  
  
  CONCLUSIONS
  Although most portal vein stenosis is asymptomatic, splenomegaly and platelet counts are 2 important markers for portal vein stenosis. Early detection of portal vein stenosis with these 2 markers can lead to successful interventional percutaneous approaches and avoid graft loss.
authors: Department of General Surgery, Başkent University Faculty of Medicine, Ankara, Turkey.
authors: H
authors: H
authors: Karakayali
authors: S
authors: S
authors: Sevmis
authors: F
authors: F
authors: Boyvat
authors: S
authors: S
authors: Aktas
authors: F
authors: F
authors: Ozcay
authors: G
authors: G
authors: Moray
authors: G
authors: G
authors: Arslan
authors: M
authors: M
authors: Haberal
mesh_terms: D002648:Child; D002675:Child, Preschool; D003251:Constriction, Pathologic / Q000473:pathology*; D005260:Female; D041981:Gastrointestinal Tract / Q000473:pathology; D006084:Graft Rejection; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D017093:Liver Failure / Q000150:complications / Q000628:therapy; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D010372:Pediatrics / Q000379:methods; D011169:Portal Vein / Q000601:surgery*; D011183:Postoperative Complications; D012189:Retrospective Studies